Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand
Crossref DOI link: https://doi.org/10.1007/s40273-018-0754-y
Published Online: 2018-12-13
Published Print: 2019-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chongmelaxme, Bunchai
Phisalprapa, Pochamana
Manthaisong, Ratree
Dilokthornsakul, Piyameth http://orcid.org/0000-0002-7750-6961
Chaiyakunapruk, Nathorn
Text and Data Mining valid from 2018-12-13
Article History
First Online: 13 December 2018